AKT1 and neoplasm: The limitations of our study require further exploration regarding the mechanism by which TMQ simultaneously activates the tumor transcriptional dysregulation pathway, and inhibits the cholinergic synaptic pathway, the AMPK signaling pathway, and the PI3K/Akt/mTOR signaling pathway, and the clinical relevance of these mechanisms.